Gottlieb previews drug price policy

The Trump administration’s drug pricing policy will include a “framework” to dismantle rules and restrictions that “shield parts of the drug industry from more vigorous competition,” FDA Commissioner Scott Gottlieb said Thursday.

Speaking at the Food and

Read the full 365 word article

User Sign In